Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 51:1098-1103, doi:10.1016/j.jacc.2007.12.010
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parolini, C.
Right arrow Articles by Chiesa, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Parolini, C.
Right arrow Articles by Chiesa, G.
Related Collections
Right arrowRelated Article

Dose-Related Effects of Repeated ETC-216 (Recombinant Apolipoprotein A-IMilano/1-Palmitoyl-2-Oleoyl Phosphatidylcholine Complexes) Administrations on Rabbit Lipid-Rich Soft Plaques

In Vivo Assessment by Intravascular Ultrasound and Magnetic Resonance Imaging

Cinzia Parolini, PhD*, Marta Marchesi, PhD*, Paolo Lorenzon*, Mauro Castano, PhD{dagger}, Elena Balconi, BS*, Luigi Miragoli{dagger}, Linda Chaabane, PhD{dagger}, Alberto Morisetti, BS{dagger}, Vito Lorusso, BS{dagger}, Bradley J. Martin, PhD{ddagger}, Charles L. Bisgaier, PhD{ddagger}, Brian Krause, PhD{ddagger}, Roger S. Newton, PhD{ddagger}, Cesare R. Sirtori, MD, PhD* and Giulia Chiesa, PhD*,*

* Department of Pharmacological Sciences, University of Milan, Milan, Italy
{dagger} Bracco Imaging SpA, Colleretto Giacosa, Turin, Italy
{ddagger} Esperion Therapeutics, Pfizer Inc., Plymouth, Michigan.


Figure 1
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Absolute Values and Percent Changes Evaluated by IVUS

Absolute values (A) and percent change (B) of total atheroma volume evaluated by IVUS at the right carotid arteries in rabbits treated with vehicle (control) or different doses of ETC-216. Data are expressed as mean ± SEM. (A) Open bars represent pre-treatment; solid bars represent post-treatment. *p < 0.05 versus control post-treatment. (B) §p < 0.05 versus control; ¶p < 0.0005 versus ETC-216 at 5 mg/kg; #p < 0.05 versus ETC-216 at 10 mg/kg. ETC-216 = recombinant apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complexes; IVUS = intravascular ultrasound.

 

Figure 2
View larger version (79K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Examples of IVUS Images of Atherosclerotic Plaques Acquired Before and After Treatment With Vehicle (Control) or 150 mg/kg ETC-216

Plaque areas are identified in yellow. A progression is visible in the control animal, whereas a regression is observed in the ETC-216–treated rabbit. Abbreviations as in Figure 1.

 

Figure 3
View larger version (10K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Percent Change in Plaque Area at the Maximum Plaque Burden Evaluated by IVUS

Rabbits were treated with vehicle (control) or ETC-216. Data are expressed as mean ± SEM. §p < 0.001 versus control; ¶p < 0.005 versus ETC-216 at 5 mg/kg; #p < 0.05 versus ETC-216 at 10 mg/kg. Abbreviations as in Figure 1.

 

Figure 4
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Absolute Values and Percent Changes Evaluated by MRI

Absolute values (A and C) and percent change (B and D) of total atheroma volume evaluated by MRI in rabbits treated five times with vehicle (control) or different doses of ETC-216. Data are expressed as mean ± SEM. (A and C) Open bars represent pre-treatment; solid bars represent post-treatment. *p < 0.05 versus control post-treatment; ^p < 0.05 versus ETC-216 at 5 mg/kg. (B and D) §p < 0.05 versus control; ¶p < 0.05 versus ETC-216 at 5 mg/kg. MRI = magnetic resonance imaging; other abbreviations as in Figure 1.

 

Figure 5
View larger version (44K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Examples of T2-Weighted Magnetic Resonance Images of Carotid Arteries Acquired at the Same Level Before and After Treatments With Vehicle (Control) or 150 mg/kg of ETC-216

Plaque areas are identified in yellow. A marked progression is visible in the control rabbit, whereas a regression is observed in the ETC-216-treated animal. Abbreviations as in Figure 1.

 

Figure 6
View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6 Percent Change of Total Atheroma Volume at MRI After 2 and 5 Administrations

Percent change of total atheroma volume at right (A) and left (B) carotid arteries evaluated by MRI after 2 and 5 administrations of vehicle or ETC-216 (40 mg/kg and 150 mg/kg). Shaded bars represent effects of 2 administrations; solid bars represent effects of 5 administrations. Data are expressed as mean ± SEM. ¶p < 0.05 versus control after 2 administrations; §p < 0.05 versus control after 5 administrations. Abbreviations as in Figures 1 and 4.

 

Figure 7
View larger version (9K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 7 Correlation Between IVUS and MRI Plaque Volume Percent Change at the RCAs

Solid triangles = control; open circles = 5 mg/kg ETC-216; solid diamonds = 10 mg/kg ETC-216; open squares = 20 mg/kg ETC-216; solid circles = 40 mg/kg ETC-216; open triangles = 150 mg/kg ETC-216 (r = 0.706; p < 0.0001). RCA = right carotid artery; other abbreviations as in Figures 1 and 4.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement